Literature DB >> 33449173

Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC.

Mengqi Huang1, Shunli Shen2, Huasong Cai1, Zhenpeng Peng1, Wan Hang Keith Chiu3, Zi-Ping Li1, Baogang Peng4, Shi-Ting Feng5.   

Abstract

OBJECTIVES: To explore the role of quantitative regional liver function assessed by preoperative gadoxetic acid-enhanced MRI with computer-aided virtual hepatectomy to predict short-term outcomes after major hepatectomy for HCC.
METHODS: We retrospectively reviewed the records of 133 consecutive patients with HCC who underwent preoperative gadoxetic acid-enhanced MRI and indocyanine green (ICG) test. Forty-five patients received open major hepatectomy. Liver function reserve and the future liver remnant were evaluated by computer-aided virtual hepatectomy. Global liver functional parameters included the T1 relaxation time reduction rate (T1ratio) and functional liver volume (FV), whereas regional parameters included the rT1pos, rT1ratio, remnant FV (rFV), and remnant FV ratio (rFVratio) of the remnant liver. The functional parameters of the MRI and ICG were used to predict the short-term outcomes (liver failure and major complications) after major hepatectomy.
RESULTS: The T1ratio and FV were correlated with the ICG test (rho = - 0.304 and - 0.449, p < 0.05). FV < 682.8 ml indicated preoperative ICG-R15 ≥ 14% with 0.765 value of the area under the curve (AUC). No patient who underwent major resection with good liver functional reserve (ICG < 14%) and enough future remnant volume (> 30% standard LV) developed liver failure. Low rT1ratio (< 66.5%) and high rT1pos (> 217.5 ms) may predict major complications (AUC = 0.831 and 0.756, respectively; p < 0.05). The rT1ratio was an independent risk factor for postoperative major complications (odds ratio [OR] = 0.845, 95% CI, 0.736-0.966; p < 0.05).
CONCLUSION: Preoperative gadoxetic acid-enhanced MRI with computer-aided virtual hepatectomy may facilitate optimal assessment of regional liver functional reserve to predict short-term outcomes after major hepatectomy for HCC. KEY POINTS: • Preoperative gadoxetic acid-enhanced MRI with virtual hepatectomy and volumetric analysis can provide precise liver volume and regional functional assessment. • Quantitative regional liver function assessed by gadoxetic acid-enhanced MRI can predict the short-term outcomes after major hepatectomy in patients with HCC. • The regional liver function assessed by gadoxetic acid-enhanced MRI is an independent risk factor for postoperative major complications.

Entities:  

Keywords:  Hepatectomy; Liver function tests; Magnetic resonance imaging; Postoperative complications

Year:  2021        PMID: 33449173     DOI: 10.1007/s00330-020-07606-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  38 in total

Review 1.  Current strategy for staging and treatment: the BCLC update and future prospects.

Authors:  Alejandro Forner; María E Reig; Carlos Rodriguez de Lope; Jordi Bruix
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

Review 2.  Evidence-based surgical care and the evolution of fast-track surgery.

Authors:  Henrik Kehlet; Douglas W Wilmore
Journal:  Ann Surg       Date:  2008-08       Impact factor: 12.969

Review 3.  Resection strategies for hepatocellular carcinoma.

Authors:  Tiffany Cho Lam Wong; Chung Mau Lo
Journal:  Semin Liver Dis       Date:  2013-08-13       Impact factor: 6.115

4.  An ordinal model to predict the risk of symptomatic liver failure in patients with cirrhosis undergoing hepatectomy.

Authors:  Mathieu Prodeau; Elodie Drumez; Alain Duhamel; Eric Vibert; Olivier Farges; Guillaume Lassailly; Jean-Yves Mabrut; Jean Hardwigsen; Jean-Marc Régimbeau; Olivier Soubrane; René Adam; François-René Pruvot; Emmanuel Boleslawski
Journal:  J Hepatol       Date:  2019-06-14       Impact factor: 25.083

5.  Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients.

Authors:  Masaya Sato; Ryosuke Tateishi; Hideo Yasunaga; Hiromasa Horiguchi; Haruhiko Yoshida; Shinya Matsuda; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-03-17       Impact factor: 7.527

6.  Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients.

Authors:  Diamantis I Tsilimigras; J Madison Hyer; Dimitrios Moris; Kota Sahara; Fabio Bagante; Alfredo Guglielmi; Luca Aldrighetti; Sorin Alexandrescu; Hugo P Marques; Feng Shen; B Groot Koerkamp; Itaru Endo; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2019-04-25       Impact factor: 3.454

7.  Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.

Authors:  Tian Yang; Jin Zhang; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu; Wei-Feng Yu
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  A Vogel; A Cervantes; I Chau; B Daniele; J M Llovet; T Meyer; J-C Nault; U Neumann; J Ricke; B Sangro; P Schirmacher; C Verslype; C J Zech; D Arnold; E Martinelli
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976

View more
  2 in total

Review 1.  Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting.

Authors:  Cher Heng Tan; Shu-Cheng Chou; Nakarin Inmutto; Ke Ma; RuoFan Sheng; YingHong Shi; Zhongguo Zhou; Akira Yamada; Ryosuke Tateishi
Journal:  Korean J Radiol       Date:  2022-05-09       Impact factor: 7.109

Review 2.  Assessment of Liver Function With MRI: Where Do We Stand?

Authors:  Carolina Río Bártulos; Karin Senk; Mona Schumacher; Jan Plath; Nico Kaiser; Ragnar Bade; Jan Woetzel; Philipp Wiggermann
Journal:  Front Med (Lausanne)       Date:  2022-04-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.